Copyright ©The Author(s) 2023.
World J Gastroenterol. Aug 14, 2023; 29(30): 4628-4641
Published online Aug 14, 2023. doi: 10.3748/wjg.v29.i30.4628
Figure 1
Figure 1 The mechanisms of action of immune checkpoint inhibitors in resectable esophageal cancer immunotherapy. CD28: Cluster of differentiation 28; CTLA-4: Cytotoxic T lymphocyte antigen 4; MHC: Major histocompatibility complex; PD-1: Programmed cell death protein 1; PD-L1: Programmed death-ligand 1; TCR: T cell receptor.